Shanghai, China

Jianbin MA

This inventor holds 1 USPTO granted patent. Top assignee: Innovstone Therapeutics Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jianbin MA. Retrieved from https://idiyas.com/inventor/jianbin-ma-k2rhy3er

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jianbin MA and His Work on PRMT5 Inhibition.

Introduction

Jianbin MA is an inventor based in Shanghai, China, and is associated with Innovstone Therapeutics Limited. His patent work focuses on a compound intended to inhibit PRMT5, an enzyme relevant to certain tumor-related diseases.

Latest Patents

MA is associated with 1 patent, titled “Compound Having Anti-Tumor Activity and Use Thereof.” The patent describes a compound represented by formula (I) and its potential use as a PRMT5 inhibitor. Reported experiments indicate that the compounds inhibit PRMT5 enzyme activity and tumor cell growth, suggesting potential for treating PRMT5-mediated diseases. The patent also describes a synthesis method characterized as straightforward and suitable for industrial-scale production and application.

Career Highlights

MA’s listed work connects medicinal chemistry research with the development of potential anti-tumor compounds. The patent’s focus includes both biological activity and a practical synthesis approach.

Collaborations

The listed coworkers associated with MA include Yongzhao Mu and Hongyan Kou. The patent is associated with Innovstone Therapeutics Limited.

Conclusion

Jianbin MA’s patent work centers on a potential PRMT5-inhibiting compound, its anti-tumor activity, and a synthesis method intended to support practical production.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…